That came from John Erb at the CC , if you go and have a listen , that is what he says, pathway to approval will be quicker with new trial protocol and end points , patients will be monitored for 6 months for improvement and lead removed at 12 moths , plus new minimally invasive technology to install CP1 . Erb says he will not dilute shareholders at these low levels, That's a buy signal to me , cheers
- Forums
- ASX - By Stock
- SHC
- interesting upgrade
interesting upgrade, page-10
-
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SHC (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online